Legal Opinion
Otsuka Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd.
District Court, D. New Jersey
Decided May 4, 2016No. Civil Action No. 14-4671 (JBS/KMW)PublishedCited by 2 opinions
1Opinion of the Court
MEMORANDUM OPINION
SIMANDLE, Chief Judge
In this Hatch Waxman Act case, see 35 U.S.C. §§ 271, 281, Plaintiff Otsuka Pharmaceutical Co, Ltd. (hereinafter, “Otsuka”) advances its position that the abbreviated new drug application (hereinafter, “AN-DAs”) of Defendants Torrent Pharmaceuticals Limited, Inc. and Torrent Pharma Inc. (collectively, “Torrent”) infringe the various patents covering Otsuka’s aripipra-zole product, Ability®.1
In the aftermath of various amendments to the parties’ pleadings, Otsuka now moves to dismiss Torrent’s Third Counterclaim for “Unlawful Monopolization in Violation of…
2Cases cited11 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Alan Schmidt v. John SkolasCourt of Appeals for the Third Circuit · 2014
- Ethypharm S.A. France v. Abbott LaboratoriesCourt of Appeals for the Third Circuit · 2013
- TransWeb, LLC v. 3M Innovative Properties Co.Court of Appeals for the Federal Circuit · 2016
- Kurt H. Eichorn v. At&T CorpCourt of Appeals for the Third Circuit · 2001
6 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC.District Court, D. Delaware · 2023
- Azurity Pharmaceuticals, Inc. v. Bionpharma Inc.District Court, D. Delaware · 2023